Intensive Update in Pain Management 2019

The Fundamentals

• Spinal Cord Stimulation – Mechanism of Action – Ricardo Vallejo, MD, PhD

• Evaluation and Treatment of Neck and Arm Pain – Following Cervical Fusion – Thomas Mroz, MD

• Sacroiliac Joint RFA: Indications, Better Technique, Better Outcomes? – David “DJ” Kennedy, MD

• Cervical Spine Surgery: Watchful Waiting vs. Decompression – Thomas Mroz, MD

• New Algorithm for Treatment of Chronic Abdominal Pain – Leo Kapural, MD, PhD

• Core Stability – David “DJ” Kennedy, MD

• Panel Discussion/Question and Answer

Regulatory, Billing and Ethical Challenges in Pain Practice

• Neuromodulation – Will Overuse Kill the Technology? – Timothy R. Deer, MD

• Effective Payer Negotiations – Damean Freas, DO

• CPT and RUC: How is a Code Created and Get Value? – Richard W. Rosenquist, MD

• Effective Billing for Neuromodulation Procedures – Robert Bolash, MD

• Medical and Ethical Concerns in Billing – Damean Freas, DO

Emerging Pharmacological and Interventional Treatment

• Basivertebral Nerve Ablation for Chronic Vertebrogenic Back Pain – David “DJ” Kennedy, MD

• The ReActiv8 Trial – Christopher J. Gilligan, MD

• CGRP Antagonists – MaryAnn Mays, MD

• Nerve Growth Factor – Mark S. Wallace, MD

• Nav1.7 as a Pharmacogenomic Target for Pain – Robert Bolash, MD

Neuromodulation: Effective Utilization of Targets, Techniques, and Devices

• Neurostimulation: From Inception to the Future – Nagy Mekhail, MD, PhD

• Tonic Stimulation – Ricardo Vallejo, MD, PhD

• Burst Stimulation – Timothy R. Deer, MD

• High Frequency Stimulation – Leo Kapural, MD, PhD

• Feedback Modified Stimulation – Nagy Mekhail, MD, PhD

• Intrathecal Drug Delivery – Robert Bolash, MD

• Dorsal Root Ganglion Stimulation – Timothy R. Deer, MD

Neuromodulation – Changing Paradigms and Devices: How Do I Choose the Best One for My Patient?

• Matching the Diagnosis and the Technique/Device for the Best Patient Outcome – A Case Discussion with the Experts – Nagy Mekhail, MD, PhD

• Panel Discussion/Question and Answer

The Opioid Crisis

• Buprenorphine: A Viable Alternative? – Robert Bolash, MD

• Pharmacogenomics: Fad or the Future? – Jennifer Hockings, PharmD, PhD

• Evolving Role of Pain Physicians in Identifying and Treating Opioid Use Disorder – Richard W. Rosenquist, MD

• Opioid Stewardship at the Enterprise Level – Christopher J. Gilligan, MD

• FDA Approved Direct to Consumer Pharmacogenomic Testing: How Do I Respond? – Jennifer Hockings, PharmD, PhD

Ketamine for Pain Medicine

• Ketamine for Chronic Pain – Samuel Samuel, MD

• Ketamine for Acute Pain – Sree Kolli, MD

• Ketamine: Miracle Drug or Latest Fad? – Teresa Dews, MD

• Contraindications to Ketamine Treatment – Samuel Samuel, MD

• Non-Pain Related Applications of Ketamine – Christopher J. Gilligan, MD

• Ketamine for CRPS – Jijun Xu, MD, PhD

• Panel Discussion/Question and Answer

Medical Marijuana

• Role of Cannabinoids in Chronic Pain Treatment – Mark S. Wallace, MD

• Adverse Effects of Cannabinoids – Scott Petersen, PA-C

• Oils, Edibles, Smoking, and Vaping: How Do You Decide? – Mark S. Wallace, MD

Headaches

• Evaluating the Headache Patient: When is Imaging Indicated? – Imanuel R. Lerman, MD

• Rational Approach to Pharmacological Migraine Treatment – MaryAnn Mays, MD

• Interventional Approaches to Headache Management – Samuel Samuel, MD

• Adverse Effects of Pharmacological Treatments – MaryAnn Mays, MD
• Panel Discussion/Question and Answe